Quality of life in the CHISEL randomized trial of stereotactic ablative radiotherapy (SABR) versus standard radiotherapy for stage I non-small cell lung cancer (Trans-Tasman Radiation Oncology Group 09.02)

D Ball; GT Mai; S Vinod; S Babington; J Ruben; T Kron; B Chesson; A Herschtal; M Vanevski; A Rezo; C Elder; M Skala; A Wirth; G Wheeler; A Lim; M Shaw; P Schofield; L Irving; B Solomon

Conference Proceedings

Quality of life in the CHISEL randomized trial of stereotactic ablative radiotherapy (SABR) versus standard radiotherapy for stage I non-small cell lung cancer (Trans-Tasman Radiation Oncology Group 09.02)

D Ball, GT Mai, S Vinod, S Babington, J Ruben, T Kron, B Chesson, A Herschtal, M Vanevski, A Rezo, C Elder, M Skala, A Wirth, G Wheeler, A Lim, M Shaw, P Schofield, L Irving, B Solomon

Annals of oncology : official journal of the European Society for Medical Oncology | ELSEVIER | Published : 2018

DOI: 10.1093/annonc/mdy445

University of Melbourne Researchers

David Ball Author

Tomas Kron Author

Andrew Wirth Author

Gregory Wheeler Author

Grants

Funding Acknowledgements

The Radiation and Optometry Section of the Australian Government Department of Health with the assistance of Cancer Australia; The Cancer Society of New Zealand; and The Cancer Research Trust, New Zealand.